Jill M. Broadfoot
Independent DirectorMs. Jill M. Broadfoot, C.P.A., serves as an Independent Director at Talphera, Inc. (formerly known as AcelRx Pharmaceuticals, Inc.) since November 20, 2021. She had been Independent Director of Otonomy, Inc. since August 18, 2021 until February 2023. She had been the Chief Financial Officer at aTyr Pharma, Inc. since July 30, 2018 until September 2026. Ms. Broadfoot is a member of the board of directors of Angiocrine Bioscience, Inc. She joined aTyr Pharma, Inc. on July 30, 2018. She was Independent Director of Cue Biopharma, Inc. since June 04, 2025 until May 29, 2026. From January 2017 to July 2018, Ms. Broadfoot served as Chief Financial Officer of Emerald Health Pharmaceuticals Inc. and Emerald Health Bioceuticals Inc. where she was responsible for establishing operations for the U.S.-based pharmaceutical and bioceuticals entities as well as the establishment of operations, corporate governance, finance and accounting and investor relations functions, among others. Prior to Emerald Health, Ms. Broadfoot served as Vice President, U.S. Corporate Controller at GW Pharmaceuticals plc, from May 2016 to January 2017. While at GW Pharmaceuticals, her responsibilities included establishing U.S. commercial operations and implementing U.S. public company financial and accounting standards in connection with the transfer of corporate operations from the U.K. to the U.S. She has held various financial positions at DJO Global. Ms. Broadfoot served as the Chief Financial Officer and Secretary of Vical Incorporated from October 2004 to April 1, 2013, where she had oversight of finance, investor relations, manufacturing, information technology, human resources and business development. Ms. Broadfoot served as Senior Vice President of Vical Incorporated from January 2009 to April 1, 2013. Ms. Broadfoot served as Principal Accounting Officer of Vical Incorporated. Ms. Broadfoot served as Vice President of Vical Inc. since October 2004. Since February 1999 until joining Vical, Ms. Broadfoot held various positions at dj Orthopedics, Inc., a publicly traded medical device company and was Vice President of Finance and Controller with broad responsibilities in finance, accounting, treasury, risk management and corporate governance. From September 1994 until joining dj Orthopedics, Ms. Broadfoot served as an audit manager at Ernst & Young LLP, where her clients included life sciences, computer software and telecommunications companies as well as government contractors. From June 1990 until joining Ernst & Young, she was Division Controller at Medical Imaging Centers of America, Inc., a chain of freestanding imaging centers and mobile imaging centers, where she held divisional accounting and financial reporting responsibilities. Ms. Broadfoot received her Bachelor of Science degree in Business Administration and Accounting from San Diego State University and is a Certified Public Accountant.
公司职务
- 公司名称Talphera, Inc.股票代码TLPH职务Independent Director
